壮医液香灸联合塞来昔布治疗项痹（颈型颈椎病）的临床观察.

Clinical Observation on the Combined Treatment of Xiangbi (Cervical Spondylosis) with Zhuang-medicine Liquid Aroma Moxibustion.

Objective To evaluate the therapeutic effect of Zhuang medicine liquid aroma moxibustion combined with celecoxib on Xiangbi (cervical spondylosis) . Methods 90 patients who met the inclusion criteria for cervical spondylosis from the Pain Clinic of Guangxi International Zhuang Medicine Hospital from January to December 2023 were selected as the research subjects. They were divided into 3 groups: the oral celecoxib control group (Group A, n = 30), the Zhuang Medicine liquid moxibustion control group (Group B, n = 30), and the Zhuang Medicine liquid moxibustion combined with celecoxib experimental group (Group C, n = 30) . During the treatment process, the Visual Analog Scale (VAS), Neck Pain Questionnaire (NPQ), Neck Disability Index (NDI), and Erythrocyte Sedimentation Rate (ESR) were used to evaluate the patients before and after treatment to understand the improvement in pain and neck function among the 3 groups of patients, ultimately summarizing the clinical efficacy of the 3 groups of patients. Results The total effective rate of group C was 93.33% (28/30), while the total effective rate of group A was 86.67% (26/30), and the total effective rate of group B was 83.33% (25/30) . Group C's overall effectiveness rate is significantly higher than that of Groups A and B (P < 0.05) . Patients in all three groups showed a significant decrease in retested VAS, NPQ, NDI scales, and Erythrocyte Sedimentation Rate (ESR) indicators after treatment compared to before, with Group C showing a greater decrease than the other 2 groups (P < 0.05) . Conclusion The combination of Zhuang medicine liquid moxibustion and Celecoxib has good efficacy in treating cervical spondylosis. Clinical evidence indicates a significant and lasting improvement in neck pain symptoms and neck mobility, enabling a rapid recovery of patients' daily self-care abilities, with no apparent adverse reactions. It is worth promoting its clinical application. [ABSTRACT FROM AUTHOR]

目的 评估壮医液香灸联合塞来昔布对项痹 (颈型颈椎病) 的治疗效果。方法 选取 2023 年 1 月 至 12 月广西国际壮医医院疼痛科门诊中符合项痹 (颈型颈椎病) 纳入标准的患者90 例为研究对象, 随机分为 3 组, 分别是口服塞来昔布对照组 (A 组, n = 30) 、壮医液香灸对照组 (B 组, n = 30), 壮医液香灸联合塞来昔 布试验组 (C 组, n = 30) 。治疗过程中使用视觉模拟评分量表 (VAS) 、颈痛量表 (NPQ) 、颈椎功能障碍指数量表 (NDI) 、红细胞沉降率 (ESR) 在治疗前后评估, 以了解 3 组患者疼痛、颈椎功能改善情况, 最终对 3 组患者的临 床疗效进行评价。结果 C 组的总有效率为 93.33% (28/30), 而 A 组的总有效率为 86.67% (26/30), B 组的总有 效率为 83.33% (25/30) 。C 组的总有效率明显高于 A、B 组 (P < 0.05) 。3 组患者在治疗后复测 VAS、NPQ、NDI 量表及红细胞沉降率 (ESR) 指标与治疗前相比都有明显降低, 且 C 组的降低幅度大于其余 2 组 (P < 0.05) 。结论 壮 医液香灸联合塞来昔布治疗项痹 (颈型颈椎病) 有较好的疗效, 临床表明可明显而持久地改善颈部疼痛症状及颈 部活动功能、快速恢复患者的日常自理能力, 且无明显不良反应, 值得临床推广应用。 [ABSTRACT FROM AUTHOR]